AllianceBernstein’s Medtronic MDT Stock Holding History

AllianceBernstein’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$574M	Sell	6,621,751 -1,199,318	-15%	-$96.7M	0.19%	104
2026 Q1	$751M	Sell	7,821,069 -1,383,693	-15%	-$133M	0.24%	81
2025 Q4	$884M	Buy	9,204,762 +1,283,282	+16%	+$125M	0.28%	65
2025 Q3	$754M	Buy	7,921,480 +2,333,686	+42%	+$215M	0.24%	71
2025 Q2	$487M	Sell	5,587,794 -797,011	-12%	-$67.6M	0.16%	109
2025 Q1	$574M	Sell	6,384,805 -920,808	-13%	-$82.4M	0.21%	92
2024 Q4	$584M	Sell	7,305,613 -2,224,285	-23%	-$193M	0.2%	89
2024 Q3	$858M	Sell	9,529,898 -1,172,386	-11%	-$98.6M	0.29%	67
2024 Q2	$842M	Sell	10,702,284 -365,756	-3%	-$30M	0.29%	63
2024 Q1	$965M	Buy	11,068,040 +571,213	+5%	+$48.7M	0.34%	56
2023 Q4	$865M	Sell	10,496,827 -292,116	-3%	-$22.3M	0.33%	61
2023 Q3	$845M	Buy	10,788,943 +923,329	+9%	+$77.3M	0.36%	56
2023 Q2	$869M	Sell	9,865,614 -97,253	-1%	-$8.37M	0.35%	57
2023 Q1	$803M	Buy	9,962,867 +79,845	+0.8%	+$6.51M	0.34%	63
2022 Q4	$768M	Buy	9,883,022 +185,665	+2%	+$15M	0.35%	64
2022 Q3	$783M	Buy	9,697,357 +881,887	+10%	+$79.3M	0.38%	52
2022 Q2	$791M	Buy	8,815,470 +325,094	+4%	+$32.9M	0.36%	51
2022 Q1	$942M	Sell	8,490,376 -977,968	-10%	-$103M	0.36%	51
2021 Q4	$980M	Buy	9,468,344 +297,646	+3%	+$34.5M	0.35%	53
2021 Q3	$1.15B	Sell	9,170,698 -248,521	-3%	-$32.2M	0.45%	38
2021 Q2	$1.17B	Sell	9,419,219 -338,129	-3%	-$42.5M	0.47%	32
2021 Q1	$1.15B	Buy	9,757,348 +95,061	+1%	+$11.1M	0.51%	29
2020 Q4	$1.13B	Buy	9,662,287 +746,294	+8%	+$82.2M	0.53%	32
2020 Q3	$927M	Buy	8,915,993 +3,191,457	+56%	+$321M	0.5%	33
2020 Q2	$525M	Sell	5,724,536 -241,477	-4%	-$23.2M	0.31%	65
2020 Q1	$538M	Buy	5,966,013 +1,200,683	+25%	+$128M	0.39%	54
2019 Q4	$541M	Buy	4,765,330 +345,464	+8%	+$37.9M	0.31%	72
2019 Q3	$480M	Buy	4,419,866 +1,507,235	+52%	+$157M	0.3%	74
2019 Q2	$284M	Sell	2,912,631 -2,617,771	-47%	-$239M	0.18%	116
2019 Q1	$504M	Sell	5,530,402 -481,437	-8%	-$43.1M	0.33%	64
2018 Q4	$547M	Buy	6,011,839 +46,234	+0.8%	+$4.32M	0.41%	54
2018 Q3	$587M	Buy	5,965,605 +545,438	+10%	+$50.4M	0.38%	58
2018 Q2	$464M	Buy	5,420,167 +178,144	+3%	+$14.9M	0.32%	69
2018 Q1	$421M	Buy	5,242,023 +414,603	+9%	+$34.2M	0.3%	73
2017 Q4	$390M	Sell	4,827,420 -253,898	-5%	-$20.3M	0.28%	83
2017 Q3	$395M	Sell	5,081,318 -988,842	-16%	-$82.1M	0.3%	82
2017 Q2	$539M	Buy	6,070,160 +3,493,058	+136%	+$295M	0.42%	52
2017 Q1	$208M	Sell	2,577,102 -127,133	-5%	-$9.93M	0.17%	128
2016 Q4	$193M	Sell	2,704,235 -3,191,751	-54%	-$251M	0.16%	133
2016 Q3	$509M	Sell	5,895,986 -1,155,319	-16%	-$101M	0.43%	49
2016 Q2	$612M	Sell	7,051,305 -4,184,203	-37%	-$338M	0.53%	37
2016 Q1	$843M	Sell	11,235,508 -443,149	-4%	-$33.4M	0.72%	20
2015 Q4	$898M	Buy	11,678,657 +725,872	+7%	+$54.6M	0.76%	19
2015 Q3	$733M	Sell	10,952,785 -453,492	-4%	-$33.4M	0.63%	24
2015 Q2	$845M	Sell	11,406,277 -258,468	-2%	-$19.7M	0.7%	21
2015 Q1	$910M	Buy	11,664,745 +2,287,471	+24%	+$173M	0.74%	21
2014 Q4	$677M	Buy	9,377,274 +3,135,621	+50%	+$218M	0.56%	29
2014 Q3	$387M	Sell	6,241,653 -2,942,573	-32%	-$187M	0.33%	72
2014 Q2	$586M	Buy	9,184,226 +344,441	+4%	+$20.9M	0.49%	36
2014 Q1	$544M	Buy	8,839,785 +532,547	+6%	+$31M	0.47%	44
2013 Q4	$477M	Sell	8,307,238 -120,305	-1%	-$6.82M	0.43%	58
2013 Q3	$449M	Buy	8,427,543 +1,488,405	+21%	+$80.1M	0.44%	50
2013 Q2	$357M	Buy	+6,939,138	New	+$343M	0.38%	65

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AllianceBernstein's MDT Position: Q2 2026 in Review

AllianceBernstein reduced its Medtronic (MDT) stake by 15% in Q2 2026, selling an estimated $96.7M and leaving 6,621,751 shares worth $574M. The position accounts for 0.19% of the portfolio, ranked #104.

AllianceBernstein first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.17B in Q2 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

AllianceBernstein held 6,621,751 shares of Medtronic worth $574M as of Q2 2026.
AllianceBernstein sold 1,199,318 Medtronic shares in Q2 2026, an estimated $96.7M.
Medtronic made up 0.19% of AllianceBernstein's portfolio in Q2 2026, its #104 holding.
AllianceBernstein first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
AllianceBernstein's Medtronic position peaked at $1.17B in Q2 2021.
2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.